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Mycotoxins are natural contaminants of cereals
and other commodities throughout the world. They
are produced by various strains of moulds,
particularly in tropical countries. Due to significant
trade of cereals, humans in temperate countries
can also be exposed to mycotoxins. The most
common route of exposure to mycotoxins is
ingestion, but it may also involve dermal,
respiratory, and parenteral routes, the last being
associated with drug abuse. Apart from acute and
chronic toxic effects on human health called
mycotoxicosis, some mycotoxins are proved or
suspected human carcinogens. This paper
describes various human diseases caused by
ergot, aflatoxin, ochratoxin A, 3-nitropropionic
acid, trichothecene, zearalenone, and fumonisin. It
also gives a quick review of human carcinogenici-
ty evaluations of the International Agency for
Research on Cancer and of regulatory limits of
mycotoxin concentrations in various commodities.
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Mould and mycotoxin contamination of food is serious although usually neglected.
According to Food and Agriculture Organization, 25% of the world crop is contami-
nated by moulds (1). Fungal invasion of agricultural commodities is common in the
fields (Fusarium spp., Aspergillus spp. and Penicillium spp.) with considerable sea-
sonal variations. Mycotoxins are usually found in mixed form. The production of mycotoxins
does not correlate directly with the growth of moulds, and while fungistatic and fun-
gicidal compounds may affect the mould invasion, this does not necessarily entail the
drop in the level of mycotoxins.
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There is no doubt about the importance of mycotoxins in the human history.
The first recognised acute intoxication was described in France in 945, when a large
number of persons were ill of ergotism (2). This potentially fatal disease, caused by
metabolites of ergot, has now almost disappeared due to the use of barley resistant
to various Claviceps strains which produce the ergot alkaloids. The importance of
application of hygienic measures in prevention of human exposure to mycotoxins was
demonstrated in the eradication of so called »yellow rice disease« (shosin-kake in
Japanese). This fatal cardiomiopathy similar to the lesions seen in beri-beri, was
caused by citreoviridin, the metabolic product of Penicillium citreonigrum (3). The
disease, common in lower social strata in Japan, disappeared immediately after the
introduction of rigorous measures which excluded mouldy (or »yellow«) rice from the
market. Another disease, that has not been seen in a severe form for decades and
which involved a large number of persons, was the »alimentary toxic aleukia« com-
mon in the USSR (4). The population was exposed to trichothecenes from unharvest-
ed wheat contaminated by Fusarium moulds.
Some moulds and products of moulds are used in food industry in the produc-
tion of cheese, sausages, beer, wine and in pharmaceutical industry as antibiotics.
The classification of mould products as antibiotics or mycotoxins is arbitrary and
depends on the toxicity of the compound.
The most common human exposure to mycotoxins is oral, that is, by ingestion
of contaminated plant-based food or of residues and metabolites in animal products,
such as aflatoxin M1. Other routes of exposure are respiratory, dermal, and parenteral,
though the last is associated with drug abuse. Respiratory exposure occurs during
professional contact with large quantities of processed contaminated food (aflatoxins
and ochratoxin A)(5–7) or the exposure occurs in highly contaminated households (8)
Table 1. Postulated human mycotoxicoses
Mycotoxin Disease or syndrome





Fumonisin B1 Oesophageal carcinoma
Fusarium metabolites Akakabi-byo
F. equiseti metabolites Kashin-beck disease
3-nitropropionic acid Mouldy cane disease
Ochratoxin A Endemic nephropathy, urothelial tumours
Trichothecenes Alimentary toxic aleukia
Zearalenone Premature telarche, cervical cancer
and office buildings with artificial ventilation (9). Dermal exposure is limited to myc-
otoxins which can pass the dermal barrier (trichothecenes) (10). Heroin abusers in the
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European countries are parenterally exposed to aflatoxin B1 which contaminates her-
oin imported from tropical countries (11).
There are several diseases which are supposed to be mycotoxin-related (Table
1). Mycotoxins are suspected to cause a disease in instances when it appears in
several persons with no obvious connection to a known etiologic agent such as mi-
cro-organisms. However, the causal relationship between exposure to mycotoxins and
the disease development should be confirmed by epidemiological studies.
Mycotoxins cause acute and chronic intoxications (mycotoxicoses), allergies, and
tumours. In experimental animals and in the experiments in vitro they may demon-
strate genotoxic, mutagenic, cytotoxic, and teratogenic properties. Some of them,
such as sporodesmine, are toxic for animals, but not for humans. Others, such as
ochratoxin A or aflatoxins, have the same target organ in all experimental animals.
For such mycotoxins it is possible to extrapolate the results from animals to humans.
The target organs of other groups of mycotoxins are so different in different animal
species that it is extremely hard to infer their effect on humans. For example, protean
mycotoxins are fumonisins, which produce pulmonary oedema in pigs, leukoenceph-
alomalacia in horses and are hepatotoxic in rats, mice, rabbits and swine and neph-
rotoxic in male swine, rats, and rabbits (12). Mycotoxicoses are more frequently no-
ticed in animals, because a large number of animals are fed with specific feed. It was
proposed that the following criteria should be met to link a mycotoxin to a specific
human disease: occurrence of mycotoxin in food samples, human exposure and
incidence, reproducibility of characteristic symptoms in experimental animals, and the
similar mode of action in human and animal models (13).
The greatest human health concern related to mycotoxins is the cancer risk
based on long-term, low-level exposure to carcinogenic toxins such as the aflatoxins,
ochratoxin A, fumonisins, and zearalenone.
ERGOT
Ergot is the common name for sclerotia of fungi of the genus Claviceps which
produce ergot alkaloids. The sclerotium is a dark coloured, hard fungal mass that
replaces the seed or kernel of the plant. Ergot alkaloids are also secondary metabo-
lites of some strains of Penicillium, Aspergillus and Rhizopus sp. (14). The source of
ergot strongly influences the type of alkaloids present, as well as the clinical picture
of ergotism (15).
Claviceps purpurea produces ergotamine-ergocristine alkaloids, which cause the
gangrenous form of ergotism because of their vasoconstrictive activity. The initial
symptoms are the leg oedema with severe pains. Paresthesias are followed by gan-
grene at the tendons with painless demarcation. In 1977–1978, Ethiopia saw the last
recorded outbreak of gangrenous ergotism striking 140 persons of whom 34% died
(16). It seems that the cause of this outbreak was the long wet season which favoured
the growth of wild oat susceptible to Claviceps purpurea.
The other type of ergotism, related to intoxication with clavine alkaloids from
Claviceps fusiformis is the convulsive form, last seen in India in 1975 and affecting
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78 persons (17). It was characterised by gastrointestinal symptoms (nausea, vomiting,
and giddiness) followed by neurological symptoms (drowsiness, prolonged sleepiness,
twitching, convulsions, blindness, and paralysis). The onset of the symptoms ranged
from one to 48 hours after ingestion of contaminated food. No fatalities were recorded.
Ergotism is extremely rare today, primarily because the standard cleaning and
milling processes remove most of ergot, leaving very low levels of the alkaloids in
flour. In addition, the alkaloids are relatively unstable and are usually destroyed by
baking and cooking.
AFLATOXINS
Aflatoxins (B1, B2, G1, and G2) are highly toxic hepatotoxins produced by various
strains of Aspergillus in tropical and subtropical regions. The first massive mycotox-
icosis which attracted scientific attention occurred in England in 1961, when tons of
groundnuts contaminated by A. flavus and A. parasiticus containing aflatoxin and
cyclopiazonic acid were used for the production of formulated feed for turkeys. The
most abundant and the most studied is aflatoxin B1 (AFB1) which together with other
aflatoxins naturally contaminates maize, sorghum, nuts, cotton seed, sunflower seed,
coffee, and other energy-rich products. When the feed consumed by cows contains
AFB1, the toxic metabolite aflatoxin M1 with toxicity similar to AFB1 is excreted in milk.
In several episodes of acute aflatoxicosis in Asia and Africa aflatoxins caused
severe lesions of liver in malnourished adults, often with the fatal outcome (18–20).
Due to seasonal appearance of childhood diseases such as kwashiorkor, Reye’s syn-
drome, and neonatal jaundice in tropical countries which coincided with periodical
high concentrations of aflatoxins in food, it was believed that aflatoxins were involved
in the etiology of these diseases. In several studies AFB1 and aflatoxicol (metabolic
product of AFB1) were found more frequently in the serum, liver, urine, and stool of
children suffering from kwashiorkor than in controls (21–24). However, it is still not
clear whether the finding of aflatoxins is the cause or the conequence of kwashiorkor.
The role of aflatoxins in the development of Reye’s syndrome (encephalopathy with
severe lesions of kidney and liver following influenza or varicella) was never proved,
regardless of frequent findings of aflatoxins in the liver of children who died of this
syndrome (25–31). The syndrome was also connected with the use of salicylates and
phenotiazines (31, 32). The last two decades saw a drop in the incidence of Reye’s
syndrome, which associated with the diminished use of salicylates in the treatment of
fever in children (33). However, a large investigation performed in Nigeria on 327
babies with jaundice and 80 matching controls proved that serum glucose-6-phos-
phate dehydrogenase deficiency and aflatoxins were significant risk factors for the
development of neonatal jaundice (34).
In the organs of experimental animals with a high incidence of tumours caused
by aflatoxin B1 (liver after oral and lungs after respiratory exposure), the DNA lesions
were caused by the formation of aflatoxin B1-DNA adducts (REDUNDANTNA RE^ENICA:
THE DNA LESIONS IN ORGANS (IN LIVER AFTER ORAL AND IN LUNGS AFTER
RESPIRATORY EXPOSURE) OF EXPERIMENTAL ANIMALS WITH A HIGH INCIDENCE
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OF TUMORS WERE CAUSED BY THE FORMATION OF AFLATOXIN B1-DNA AD-
DUCTS. A good correlation of aflatoxin B1-DNA adducts production in target organs
and aflatoxin B1-DNA adducts on albumin and their excretion in urine was found. The
production of aflatoxin B1-DNA adducts depends on exposure, nourishment, the in-
take of antioxidants, viral infection, and genetic polymorphism (35). It was also found
that AFB1 triggers mutation of the p53 tumour suppressor gene.
The incidence of primary liver carcinoma is unusually high in some African and
Asian regions. Exposure to aflatoxins and of the incidence of primary liver carcinoma
were investigated in Thailand (36), Kenya (37), Mozambique (38), Swaziland (39), and
Mozambique/Transkei (40). Although the populations of those countries were not
serologically tested for HbsAg, the results pointed to the role of aflatoxins in the
development of this disease. The role of aflatoxins in the development of the primary
liver carcinoma, irrespective of the hepatitis B virus, was confirmed in investigations
performed in China and Swaziland (41–43). Based on these data, the Working Group
of the International Agency for Research on Cancer (44) declared in 1987 that there
was enough evidence of the carcinogenicity of aflatoxin in humans. In 1992, another
group of scientists relied on the epidemiological data to declare that there was enough
evidence that the mixture of aflatoxins was hepatocarcinogen in humans and that the
metabolite aflatoxin M1 was a potential hepatocarcinogen in humans (45). A study in
Taiwan showed that the risk of development of the primary liver carcinoma is consid-
erably higher if the exposure to aflatoxin is combined with the presence of hepatitis
B virus. The authors believe that the hepatitis B vaccination could be an effective
prevention of tumours in countries with high aflatoxin contamination (35).
Aflatoxins are considered unavoidable contaminants of food, since they cannot
be prevented or eliminated by the current agricultural practice. However, blanching
and electronic eye colour sorting may reduce the concentration of total aflatoxins to
5 µg/kg of peanuts (46). Specific limits have already been set in a number of coun-
tries and they range from 0 to 30 µg/kg for aflatoxin B1 in foodstuffs and from 0 to
50 µg/kg for total aflatoxins.
OCHRATOXIN A
Ochratoxins are a group of mycotoxins produced during grain storage by several
Penicillium and Aspergillus strains all over the world (47). The most toxic and the
most frequent is ochratoxin A (OTA), found in various commodities of plant and
animal origin such as cereals, coffee, bread, wine, beer, pork meat, sausages, eggs,
and milk.
OTA has been shown to be nephrotoxic, immunosupressive, carcinogenic, and
teratogenic in all experimental animals tested so far. Owing to the similarity of mor-
phological and functional kidney lesions in OTA-induced porcine nephropathy, this
mycotoxin has been proposed as the causative agent of endemic nephropathy (48).
Endemic nephropathy occurs in rural population of some regions of Croatia, Bosnia
and Herzegovina, Yugoslavia, Bulgaria, and Romania. It has been estimated that about
20,000 people are either suffering from or are suspect of the disease (49). The main
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features of this fatal renal disease are bilateral, primarily chronic lesions of the renal
cortex (tubular degeneration, interstitial fibrosis, and hyalinisation of the glomeruli)
(50). Many samples of food and feed produced in the endemic area of Croatia con-
tained ochratoxin A (51–53). It was recently shown that concentrations of OTA in
maize samples collected in the endemic regions in years with favourable climate for
the production of ochratoxin A were higher than in other regions of Croatia (54).
Blood ochratoxin A is found more frequently and in higher concentrations in inhab-
itants from endemic regions than in controls (53, 55).
In Tunisia, ochratoxin A has been detected in high concentration in the blood
and food of patients with kidney impairment of unknown etiology (56, 57). In Italy,
significantly higher OTA concentration was found in patients treated with dialysis than
in transplanted subjects, patients with chronic glomerulonephritis, renal calculus, cysts,
chronic renal failure and healthy subjects (58). It is not clear weather the high concen-
tration of OTA in blood of patients with serious impairment of kidney function is
caused by this mycotoxin or it is only the consequence of reduced glomerular filtra-
tion rate.
Furthermore, OTA was found in food and feed in a number of countries where
endemic nephropathy has not been recorded so far (47). Although it was frequently
found in low concentration in human blood (59), the significance of such finding is
not clear.
In endemic regions of Croatia, Bulgaria, and Yugoslavia, the respective incidence
of otherwise rare urothelial tumours of the pelvis and urethra is 50, 90, and 100 times
greater than in non-endemic regions (60–62). As the incidence, clinical course, and
prognosis of those tumours differs from urothelial tumours found in non-endemic
regions, it was suggested that OTA may be the causal agent for both endemic neph-
ropathy and urothelial tumours (63).
International Agency for Research on Cancer classified ochratoxin A as a com-
pound possibly carcinogenic to humans (Group 2B) (44). Regulatory limits for OTA
in various food have been set in six, mostly Scandinavian countries and range be-
tween 1 and 300 µg/kg.
3-NITROPROPIONIC ACID
3-nitropropionic acid (3-NPA) is the secondary metabolite of Arthrinium sp. consid-
ered to cause acute food-poisoning called »Mouldy sugarcane poisoning« (MSP) (64).
MSP occurs in winter (February and March) in 13 provinces of Northern China as a
consequence of the ingestion of sugarcane stored for two months or longer and
infested with Arthrinium sp. In the period 1972–88, 884 persons were affected by the
outbreaks of MSP and 88 (10%) died (65). The main epidemiological feature is the
small number of persons in one outbreak (one to five persons), victims being mostly
children and young persons (65). Generally, the incubation period is 2–3 hours after
ingestion of mouldy sugar cane, and the main clinical symptoms are vomiting, dys-
tonia, stare to one side, convulsions, carpopedal spasm, and coma. Delayed dystonia
develops in 10–50% of patients as the consequence of bilateral symmetric necrosis of
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the basal ganglia. The development of delayed symptoms may be predicted by ab-
normal basal ganglia visible on cranial computerised tomography scans (66). In adults
3-NPA causes gastrointestinal symptoms, whereas signs of severe encephalopathy are
not common (67).
TRICHOTHECENES
Trichothecenes are large group of 148 mycotoxins, produced mostly by Fusarium
genus, although other genera (e.g. Trichoderma, Trichotecium, Myrothecium, and
Stachybotrys) are also known to produce these compounds (68). Mycotoxins produc-
ing strains of Fusarium contaminate grain with mycotoxins in fields throughout the
world (69) The most frequent contaminants are deoxynivalenol (DON), also known as
vomitoxin, nivalenol (NIV), and diacetoxyscirpenol (DAS), while T-2 toxin is rarer (68).
The most severe manifestations of trichothecene toxicity with the fatal outcome
in 60% of involved persons were seen in the USSR from 1932 to 1947 (4). This
trichothecenes mycotoxicosis called »alimentary toxic aleukia« was the consequence
of grain contamination with Fusarium sporotrichoides. The contamination of grain
samples taken from the affected regions was 5–40%, whereas the regions not affect-
ed by the disease showed only a 2–8% contamination of samples with the fungus.
The initial symptoms were gastritis, gastro-enteritis, abdominal and oesophageal pain,
and diarrhoea. Longer consumption of contaminated grain (3–4 weeks) entailed gen-
eralised indisposition with vertigo, unpleasant taste in the mouth with progressive
leukopenia, granulocytopenia, and lymphocytosis. In the terminal phase of the dis-
ease the patients had haemorrhagic diathesis and angina with petechial rash, catarrh-
al diphteric gangrenous laryngitis, aphonia, and asphyxia.
More recent outbreaks of trichothecenes mycotoxicoses were less severe and
without the fatal outcome. Trichothecenes mycotoxicosis, called also »scabby grain
toxicosis«, occurred in Japan (70), China (71, 72), and India (73, 74). The main
symptoms were abdominal pain, nausea, vomiting, diarrhoea, dizziness, and head-
ache. The symptoms usually appeared within hours after the ingestion of wheat, corn,
or rice contaminated by DON, NIV, T-2 toxin, deoxynivalenol, and zearalenon.
The regulatory limit in wheat for deoxynivalenol is from 1000 to 4000 µg/kg in
five countries, and for diacetoxyscirpenol 100 µg/kg in Israel. The limit for T-2 toxin
is 100 µg/kg in two countries.
ZEARALENONE
Zearalenone (previously known as F-2 toxin) is a mycotoxin generated in the field or
during storage of humid grain contaminated by various Fusarium spp. in the pre-
harvest period. It is often found together with other Fusarium mycotoxins on maize,
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wheat, and other cereals. Contrary to the other Fusarium mycotoxins, zearalenone is
more frequently found in ecologically than in conventionally produced wheat (75).
Zearalenone and its metabolic products may be found in food of animal origin (meat,
milk, and cheese) (76).
Zeranol, a growth-promoting derivative of zearalenone, has been approved by the
USA Food and Drug Administration for use in animal husbandry instead of diethylstil-
bestrol. Zeranol is formed in cattle in vivo from feed contaminated by zearalenone
(77).
In experimental and domestic animals zearalenone and zeranol have uterotrophic
effect, and, being weak oestrogens, they cause inhibition of the hypothalamus and
anterior pituitary and the atrophy of the ovaries, testes, prostate, and seminal vesicles
(78–80). There are several reports on breast enlargement and precocious sexual de-
velopment of children possibly connected with food-related exposure to oestrogens.
In Puerto Rico, zearalenone was found in the blood of children with precocious sexual
development (81). As maize is not produced in Puerto Rico, the authors believe that
the affected children consumed chicken meet fed on the fodder imported from the
USA. Since 1989, the south-east part of Hungary has been recording an ever increas-
ing number of telarche and mastopathy in patients most of whom consumed »healthy«
food (82). Zearalenone was found in 5 out of 36 serum samples.
The carcinogenicity of zearalenone for humans could not be evaluated because
of the absence of epidemiological data (44).
FUMONISINS
Fumonisins are the most recent isolated group of mycotoxins. They are produced by
Fusarium verticillioides (Sacc.), Nirenberg (=Fusarium moniliforme Sheldon), and
related species on maize that has been affected by the moulds before the harvest.
Maize and maize products may contain significant amounts of fumonisins, and fumo-
nisin contamination of maize was found in many countries (83) including Croatia (54).
Fumonisins are heat-stable (84), light-stable, and water soluble (45). Natural contam-
ination of maize by fumonisin B1 is more frequent than contamination with the other
14 fumonisins (12).
Thanks to poor absorption and rapid excretion in animals, fumonisins are not
significantly transferred into pork, chicken meat, eggs, and milk (85, 86). Fumonisins
disturb the sphingolipid metabolism, and the resulting increase in the sphinganine/
sphingosine ratio is used as a biomarker of animal exposure. It was shown that the
target organs of fumonisin toxicity are liver (mice, rats, equids, rabbits, pigs, and non-
human primates), kidney (pigs, rats, sheep, mice, and rats), brain (horses), and lungs
(pigs) (12). The carcinogenicity of fumonisin B1 in rodents varies between species,
strains, and the sexes.
A single outbreak of acute human mycotoxicosis was reported in 27 villages of
India, when the poorest social strata were exposed to fumonisin B1 in mouldy maize
and sorghum (87). Fumonisin B1 was found in much higher concentrations in food
consumed by the affected than by the control households. The main features of the
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disease were transient abdominal pain, borborygmus, and diarrhoea which started
half an hour to one hour after the consumption of unleavened bread.
In some regions of Africa (Transkei), Asia (China), and Europe (Italy) the expo-
sure to fumonisins from maize is connected with higher incidence of oesophageal
cancer (45).
Fumonisins have a weak cancer-initiating and a strong cancer-promoting poten-
tial, which was proved on rats which developed hepatocellular carcinoma and cholan-
giocarcinoma. The promoting potential of fumonisins is suspected to be the caus-
ative agent of the primary liver carcinoma which is very frequent in the Chinese region
of Haimen (88). Concentrations of aflatoxin B1, deoxynivalenol and fumonisins B1, B2,
and B3 were measured in samples of maize from Haimen and Penlai, a region with
low incidence of the primary carcinoma. The aflatoxin concentration was low and the
incidence of aflatoxin positive findings was similar in both regions, but the concentra-
tions of fumonisins and deoxynivalenol were much higher in Haimen.
An IARC working group classified the toxins from F. moniliforme as possibly
carcinogen to humans (Group 2B) (44). Limits for human daily exposure, as well as
the limits of fumonisins in maize are yet to be determined.
CONCLUSIONS
Mycotoxins are frequent food contaminants. Validated analytical methods for myc-
otoxins in various commodities should be accepted all over the world to enhance the
control of food quality. International organizations (World Health Organization and
Food and Agriculture Organization) have recommended regulatory levels and the
tolerable daily intake for most mycotoxins, yet those do not oblige national legisla-
tions to introduce them. Regulatory levels of mycotoxins should follow the ALARA (as
low as reasonably achievable) principles in order to reduce grain trade barriers. The
main scope of all these efforts is to decrease the risk of mycotoxin exposure.
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Sa‘etak
MIKOTOKSINI U HRANI I NJIHOV U^INAK NA LJUDSKO ZDRAVLJE
Mikotoksini su metaboliti plijesni ~ija va‘nost za rast i razvoj plijesni nije razja{njena. Ti spojevi vrlo razli~itih
kemijskih struktura one~i{}uju ‘itarice i druge namirnice osobito u tropskim krajevima, jer vi{a temperatura i
vla‘nost pogoduju rastu plijesni. ^ovjek je naj~e{}e izlo‘en mikotoksinima putem hrane, no u nekim slu~ajevima
mo‘e do}i do njihova udisanja, prolaska kroz ko‘u ili parenteralne izlo‘enosti. Akutno i kroni~no o{te}enje zdravlja
zbog djelovanja mikotoksina naziva se mikotoksikoza, a za neke se mikotoksine pretpostavlja ili je dokazano da su
karcinogeni za ljude. U ovom radu opisani su razli~ite bolesti ili sindromi u ljudi koje uzrokuju alkaloidi ergota,
aflatoksini, okratoksin A, 3-nitropropionska kiselina, trihoteceni, zearalenon i fumonizini. Iznesene su i procjene
Me|unarodne agencije za istra‘ivanje karcinoma o karcinogenosti pojedinih mikotoksina, kao i zakonski propisi o
dopu{tenim koncentracijama pojedinih mikotoksina u razli~itim namirnicama.
Klju~ne rije~i:
3-nitropropionska kiselina, aflatoksini, fumonizini, hrana, ljudi, mikotoksikoze, mikotoksini, okratoksin A, trihoteceni,
zearalenon
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